CLINICAL_TRIALS
trial_result
· 2013-06-10
Clinical Trial Update: Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating danazol for advanced or recurrent endometrial cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED